Seems to me, the way it reads, Excellagen is approved and working in the 17 indications. Add’l indications and treatments will require minimum funding to get a room stable product. So this does not hinder sales at VA at all. But if we want to treat add’l ailments, then we need an advanced product.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.